# SPINK7

## Overview
SPINK7 is a gene that encodes the serine peptidase inhibitor Kazal type 7, a protein primarily involved in the inhibition of serine proteases. This protein is characterized by its Kazal-type domains, which are crucial for its function as a protease inhibitor. The SPINK7 protein plays a significant role in maintaining tissue homeostasis and protecting epithelial cells from protease-mediated damage, particularly within the gastrointestinal tract (Zhao2021Neutrophilsderived; Dong2021SPINK7). It is also implicated in immune defense mechanisms, where it is upregulated in response to infections and participates in immune cell aggregation (Dong2021SPINK7). Beyond its physiological roles, SPINK7 has been identified as a tumor suppressor, with its expression often reduced in various cancers, including esophageal and oral squamous cell carcinomas (Patel2024ECRG2SPINK7; Pennacchiotti2021SPINK7). The gene's involvement in both immune response and cancer suppression underscores its importance in cellular integrity and disease prevention.

## Structure
The SPINK7 protein, also known as ECRG2, is a serine protease inhibitor characterized by the presence of Kazal-type domains. The primary structure of SPINK7 includes 194 amino acids, with a predicted signal peptide of 19 amino acids at the N-terminal, suggesting it may be secreted extracellularly (Dong2021SPINK7). The mature protein has a theoretical molecular weight of 18.8 kDa and an isoelectric point of 4.7 (Dong2021SPINK7). 

The secondary structure of SPINK7 includes one α helix and a three-stranded anti-parallel β-sheet within its Kazal domains, which are evolutionarily conserved and typically consist of 40-60 amino acids (Patel2024ECRG2SPINK7). These domains contain six conserved cysteine residues that form three intramolecular disulfide bridges, crucial for maintaining the protein's stability and function (Dong2021SPINK7; Patel2024ECRG2SPINK7).

SPINK7 does not have a reported quaternary structure involving multiple subunits. The protein is involved in inhibiting serine proteases such as trypsin and chymotrypsin, and it plays a role in immune defense and cancer suppression (Dong2021SPINK7; Patel2024ECRG2SPINK7). The protein's ability to bind to proteases and its involvement in various biological processes are attributed to its structural features.

## Function
SPINK7, or serine peptidase inhibitor Kazal type 7, functions primarily as a serine protease inhibitor, playing a crucial role in regulating proteolytic activity. This regulation is essential for maintaining tissue homeostasis and protecting epithelial cells from protease-mediated damage. SPINK7 is particularly active in the gastrointestinal tract, where it helps maintain mucosal integrity by inhibiting excessive proteolytic activity that could otherwise lead to tissue damage (Zhao2021Neutrophilsderived).

The protein encoded by SPINK7 contains three Kazal domains, each with six conserved cysteine residues that form disulfide bridges, contributing to its structural stability and function. These domains are homologous to those found in other species, indicating a conserved role in protease inhibition (Dong2021SPINK7). SPINK7 is known to inhibit proteases such as trypsin and chymotrypsin, which are involved in various physiological processes, including digestion and immune responses (Dong2021SPINK7).

In the context of immune function, SPINK7 is upregulated in response to fungal infections, suggesting a role in immune defense. It binds to fungal components, promoting immune cell aggregation and encapsulation, which are key processes in the innate immune response (Dong2021SPINK7). This indicates that SPINK7 not only regulates proteolytic activity but also participates in immune surveillance and response.

## Clinical Significance
Alterations in the expression of the SPINK7 gene, also known as ECRG2, have been linked to several diseases and conditions. In eosinophilic esophagitis (EoE), a chronic inflammatory condition of the esophagus, SPINK7 expression is significantly decreased. This reduction impairs epithelial barrier function and increases the production of pro-inflammatory cytokines, contributing to allergic inflammation and epithelial-mesenchymal transition (EMT) in the esophagus (Azouz2023Aryl; Rochman2018Epithelial).

In the context of cancer, SPINK7 acts as a tumor suppressor gene. Its expression is often absent or reduced in esophageal squamous cell carcinoma and other malignancies, such as oral squamous cell carcinoma (OSCC). In OSCC, SPINK7 downregulation is associated with disease progression and is considered a potential biomarker for predicting cancer stages (Patel2024ECRG2SPINK7; Pennacchiotti2021SPINK7). The gene's loss of function is linked to increased cancer cell proliferation, migration, invasion, and metastasis (Patel2024ECRG2SPINK7).

SPINK7 also plays a role in maintaining chromosome stability. Its disruption can lead to centrosome amplification and chromosomal instability, which are precursors to cancer (Patel2024ECRG2SPINK7). These findings highlight the clinical significance of SPINK7 in both inflammatory and cancerous conditions.

## Interactions
SPINK7, also known as ECRG2, is involved in several protein interactions that influence its biological functions. It forms a complex with urokinase-type plasminogen activator (uPA) and its receptor uPAR, inhibiting the uPA pathway. This interaction disrupts the uPA/plasmin and MMP2-mediated proteolytic activity, preventing uPAR's interaction with integrins and subsequent activation of the Src/ERK pathway, which suppresses extracellular matrix degradation and cancer cell invasion (Patel2024ECRG2SPINK7). SPINK7 also interacts with the p53 pathway, where it is a pro-apoptotic transcriptional target of p53. DNA-damaging agents increase p53 binding to the ECRG2 promoter, leading to its induction (Patel2024ECRG2SPINK7).

SPINK7 is involved in centrosome amplification and chromosome segregation, with its deletion leading to chromosomal instability. It interacts with metallothionein 2A (MT2A) and modulates proteins like HuR and XIAP, selectively inducing apoptosis in cancer cells (Patel2024ECRG2SPINK7). SPINK7's interaction with the long noncoding RNA HCG22 and miR-1322 suggests its regulation by these molecules, which may serve as potential diagnostic biomarkers (Liao2022SPINKs). These interactions highlight SPINK7's role in inhibiting tumor progression and maintaining cellular integrity.


## References


[1. (Liao2022SPINKs) Chengcheng Liao, Qian Wang, Jiaxing An, Minglin Zhang, Jie Chen, Xiaolan Li, Linlin Xiao, Jiajia Wang, Qian Long, Jianguo Liu, and Xiaoyan Guan. Spinks in tumors: potential therapeutic targets. Frontiers in Oncology, February 2022. URL: http://dx.doi.org/10.3389/fonc.2022.833741, doi:10.3389/fonc.2022.833741. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.833741)

2. (Azouz2023Aryl) Aryl Hydrocarbon Receptor Suppresses Eosinophilic Esophagitis Responses through OVOL1 and SPINK7. This article has 0 citations.

[3. (Zhao2021Neutrophilsderived) Na Zhao, Guojian Wang, Shuang Long, Dengqun Liu, Jining Gao, Yang Xu, Cheng Wang, Aiping Wang, Fengchao Wang, Yuhui Hao, Xinze Ran, Junping Wang, Yongping Su, and Tao Wang. Neutrophils-derived spink7 as one safeguard against experimental murine colitis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1867(6):166125, June 2021. URL: http://dx.doi.org/10.1016/j.bbadis.2021.166125, doi:10.1016/j.bbadis.2021.166125. This article has 3 citations.](https://doi.org/10.1016/j.bbadis.2021.166125)

[4. (Patel2024ECRG2SPINK7) Harsh Patel, M. Saeed Sheikh, and Ying Huang. Ecrg2/spink7 tumor suppressor as modulator of dna damage response. International Journal of Molecular Sciences, 25(11):5854, May 2024. URL: http://dx.doi.org/10.3390/ijms25115854, doi:10.3390/ijms25115854. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25115854)

[5. (Dong2021SPINK7) Zhaoming Dong, Lingna An, Mengyao Lu, Muya Tang, Haiqin Chen, Xuan Huang, Yong Hou, Guanwang Shen, Xiaolu Zhang, Yan Zhang, Qingyou Xia, and Ping Zhao. Spink7 recognizes fungi and initiates hemocyte-mediated immune defense against fungal infections. Frontiers in Immunology, September 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.735497, doi:10.3389/fimmu.2021.735497. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.735497)

[6. (Rochman2018Epithelial) Mark Rochman, Nurit P. Azouz, and Marc E. Rothenberg. Epithelial origin of eosinophilic esophagitis. Journal of Allergy and Clinical Immunology, 142(1):10–23, July 2018. URL: http://dx.doi.org/10.1016/j.jaci.2018.05.008, doi:10.1016/j.jaci.2018.05.008. This article has 73 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2018.05.008)

[7. (Pennacchiotti2021SPINK7) Gina Pennacchiotti, Fabio Valdés-Gutiérrez, Wilfredo Alejandro González-Arriagada, Héctor Federico Montes, Judith Maria Roxana Parra, Valeria Andrea Guida, Silvina Esther Gómez, Martin Eduardo Guerrero-Gimenez, Juan Manuel Fernandez-Muñoz, Felipe Carlos Martin Zoppino, Rubén Walter Carón, Marcelo Eduardo Ezquer, Ricardo Fernández-Ramires, and Flavia Alejandra Bruna. Spink7 expression changes accompanied by her2, p53 and rb1 can be relevant in predicting oral squamous cell carcinoma at a molecular level. Scientific Reports, March 2021. URL: http://dx.doi.org/10.1038/s41598-021-86208-z, doi:10.1038/s41598-021-86208-z. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-021-86208-z)